Victory Capital Management Inc Adaptive Biotechnologies Corp Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Victory Capital Management Inc holds 18,065 shares of ADPT stock, worth $91,770. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,065

Previous 18,373 1.68%

Holding current value

$91,770

Previous $66,000 39.39%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$3.37 - $5.12 $1,037 - $1,576	-308 Reduced 1.68%	18,065 $92,000
Q2 2024 Aug 05, 2024	SELL	$2.34 - $3.96 $699 - $1,184	-299 Reduced 1.6%	18,373 $66,000
Q1 2024 May 03, 2024	SELL	$2.88 - $4.8 $1,195 - $1,992	-415 Reduced 2.17%	18,672 $59,000
Q4 2023 Feb 05, 2024	BUY	$3.46 - $5.33 $12,141 - $18,702	3,509 Added 22.53%	19,087 $93,000
Q3 2023 Nov 06, 2023	BUY	$5.07 - $8.44 $1,059 - $1,763	209 Added 1.36%	15,578 $84,000
Q2 2023 Jul 27, 2023	SELL	$6.19 - $8.78 $2,216 - $3,143	-358 Reduced 2.28%	15,369 $103,000
Q1 2023 May 02, 2023	SELL	$7.8 - $10.11 $1,279 - $1,658	-164 Reduced 1.03%	15,727 $138,000
Q4 2022 Feb 10, 2023	BUY	$6.26 - $9.34 $901 - $1,344	144 Added 0.91%	15,891 $121,000
Q4 2022 Feb 09, 2023	SELL	$6.26 - $9.34 $939 - $1,401	-150 Reduced 0.94%	15,747 $120,000
Q3 2022 Nov 02, 2022	SELL	$6.5 - $12.67 $7,065 - $13,772	-1,087 Reduced 6.4%	15,897 $113,000
Q2 2022 Aug 01, 2022	BUY	$6.4 - $14.73 $20,262 - $46,635	3,166 Added 22.91%	16,984 $137,000
Q1 2022 May 04, 2022	BUY	$10.12 - $28.9 $2,702 - $7,716	267 Added 1.97%	13,818 $114,000
Q4 2021 Feb 07, 2022	SELL	$25.17 - $36.85 $379,186 - $555,145	-15,065 Reduced 52.65%	13,551 $380,000
Q3 2021 Nov 02, 2021	SELL	$30.02 - $39.87 $13,088 - $17,383	-436 Reduced 1.5%	28,616 $973,000
Q2 2021 Aug 03, 2021	BUY	$32.22 - $44.59 $46,654 - $64,566	1,448 Added 5.25%	29,052 $1.19 Million
Q1 2021 May 04, 2021	SELL	$37.26 - $67.74 $1.04 Million - $1.9 Million	-28,017 Reduced 50.37%	27,604 $1.11 Million
Q4 2020 Feb 01, 2021	SELL	$45.01 - $65.47 $225,500 - $328,004	-5,010 Reduced 8.26%	55,621 $3.29 Million
Q3 2020 Nov 09, 2020	SELL	$35.79 - $48.81 $288,037 - $392,822	-8,048 Reduced 11.72%	60,631 $2.95 Million
Q2 2020 Aug 07, 2020	SELL	$24.95 - $48.38 $2.5 Million - $4.84 Million	-100,110 Reduced 59.31%	68,679 $3.32 Million
Q1 2020 May 04, 2020	BUY	$16.96 - $34.16 $1.57 Million - $3.16 Million	92,383 Added 120.91%	168,789 $4.69 Million
Q4 2019 Feb 06, 2020	SELL	$24.56 - $32.8 $2.37 Million - $3.16 Million	-96,437 Reduced 55.79%	76,406 $2.29 Million
Q4 2019 Feb 04, 2020	BUY	$24.56 - $32.8 $2.08 Million - $2.78 Million	84,833 Added 96.39%	172,843 $5.17 Million
Q3 2019 Nov 12, 2019	BUY	$30.31 - $53.51 $818,673 - $1.45 Million	27,010 Added 44.28%	88,010 $2.72 Million
Q2 2019 Aug 15, 2019	BUY	$40.3 - $48.3 $2.46 Million - $2.95 Million	61,000 New	61,000 $2.95 Million

Others Institutions Holding ADPT

# of Institutions

201

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $726M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Adaptive Biotechnologies Corp Transaction History